Close

This is a StreetInsider.com Premium Only Page

Please sign-up to enjoy all the benefits of StreetInsider.com Premium or log-in if you're already a member.

Send to a Friend Font Size: Increase Decrease

Back to CMPS Stock Lookup

(CMPS) – PRNewswire

May 30, 2023 07:00 AM Numinus to research COMP360 psilocybin therapy in treatment-resistant depression as part of large phase 3 study

Back to CMPS Stock Lookup